Patents Examined by Laura R. C. Lutz
  • Patent number: 5912358
    Abstract: 2-Pyrrolidones can be prepared by simultaneous reaction of maleic acid, ammonia or a primary amine and hydrogen at elevated temperature and elevated pressure in the liquid phase over a supported catalyst, with the supported catalyst containing both palladium and rhenium in metallic or bound form.
    Type: Grant
    Filed: May 24, 1996
    Date of Patent: June 15, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Lutz Frohn, Jorg-Dietrich Jentsch, Eberhard Zirngiebl
  • Patent number: 5900427
    Abstract: This invention relates to the use of heteroarenesulfonyl groups as protecting groups for amino groups, particularly the amino groups of amino acids, and specifically to nitrogen-protected (N-protected) amino acid reagents, which are particularly well-suited for use in peptide syntheses. In particular, the N-protected amino acid reagent is an N-heteroarenesulfonyl-protected amino acid halide. The heteroarenesulfonyl protecting groups are readily removed under relatively mild conditions.
    Type: Grant
    Filed: May 3, 1996
    Date of Patent: May 4, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Edwin Vedejs, Jiabing Wang, Shouzhong Lin, Artis Klapars
  • Patent number: 5877204
    Abstract: The present invention relates to compounds which are useful as sunscreens. The compounds persist on the skin for much longer than conventional sunscreens because they comprise a Michael acceptor linked directly or indirectly to a chromophore. The Michael acceptor is capable of undergoing a conjugate addition reaction with thiol groups present in cysteine residues of keratin and thus the compound is chemically bound to the skin and will not be removed by immersion in water.
    Type: Grant
    Filed: November 5, 1996
    Date of Patent: March 2, 1999
    Assignee: Vanguard Medica Limited
    Inventors: Bruce Everett Davison, Bryan Colin Nicholas Morgan Jones, Charon Robin Ganellin, Paul Beaumont Bishop, David Jack
  • Patent number: 5869532
    Abstract: Taurine derivatives represented by the following formula (1) and cleanser compositions containing the same: ##STR1## wherein R is a linear or branched alkyl or alkenyl group having 5 to 21 carbon atoms, and M.sub.1 and M.sub.2 are the same or different from each other and each independently is a hydrogen atom, an alkali metal atom, 1/2 (an alkaline earth metal atom), an ammonium group, etc.,are excellent in foaming, detergency, comfort in use, rinsability, safety and biodegradability and are employed as a cleanser for the hair and body or tableware.
    Type: Grant
    Filed: August 19, 1996
    Date of Patent: February 9, 1999
    Assignee: Kao Corporation
    Inventors: Hiromoto Mizushima, Masakatsu Takahashi, Hiroe Tanahashi, Takashi Matsuo
  • Patent number: 5869679
    Abstract: Method for synthesizing L-2-oxothiazolidine-4-carboxylate and its acid, L-2-oxothiazolidine-4-carboxylic acid. The present invention involves the separation of phenol from a reaction mixture containing L-2-oxothiazolidine-4-carboxylate and phenol. In the present method a reaction mixture containing phenol, L-2-oxothiazolidine-4-carboxylate, and chloride salt, is contacted with a phenol adsorbing adsorption resin, the adsorption resin comprising a polymer having a polyethylene backbone. The adsorption resin is capable of adsorbing substantially all of the phenol while not adsorbing substantial amounts of the L-2-oxothiazolidine-4-carboxylate from the reaction mixture.
    Type: Grant
    Filed: November 10, 1997
    Date of Patent: February 9, 1999
    Assignee: Transcend Therapeutics, Inc.
    Inventors: Francis H. Verhoff, L. Reade Baxley, Xiaofeng Lin, Gordon J. Rossiter
  • Patent number: 5869492
    Abstract: Compounds of formula I ##STR1## in which A is S(O).sub.p or O;p is 0, 1 or 2;g is 0, 1, 2, 3, or 4;n is 2 or 3; andR.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are optional substituents have utility in the treatment of central nervous system disorders, for example depression, anxiety, psychoses (for example schizophrenia), tardive dyskinesia, obesity, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, senile dementia, cerebral ischemia, obsessive-compulsive behavior, panic attacks, social phobias, eating disorders and anorexia, non-insulin dependent diabetes mellitus, hyperglycemia, and stress.
    Type: Grant
    Filed: December 15, 1997
    Date of Patent: February 9, 1999
    Assignee: Knoll Aktiengesellschaft
    Inventors: Frank Kerrigan, Sharon Crawford Cheetham, Roy Victor Davies
  • Patent number: 5869427
    Abstract: A novel substituted thiophene derivatives represented by the formula (1) in the invention: ##STR1## wherein R is a straight or branched alkyl group having 3-12 carbon atoms, straight or branched halogenoalkyl group having 3-12 carbon atoms, straight or branched alkenyl group having 3-10 carbon atoms, straight or branched halogenoalkenyl group having 3-10 carbon atoms, or cycloalkyl group having 3-10 carbon atoms, the cycloalkyl group being unsubstituted or substituted with an alkyl group having 1-4 carbon atoms, R and --NHCOAr are adjacent to each other, and Ar is a heterocyclic group; have excellent control activity on various plant disease such as Gray mold, Powdery mildew, Blast and Rust, and are useful as a plant disease control agent due to outstanding residual effect on Botrytis cinerea and excellent effect on Gibberella zeae.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: February 9, 1999
    Assignee: Mitsui Chemicals, Inc.
    Inventors: Yukihiro Yoshikawa, Kanji Tomiya, Toshio Kitajima, Hiroyuki Katsuta, Osamu Takahashi, Shunichi Inami, Yuji Yanase, Naofumi Tomura, Junro Kishi, Hideo Kawasima
  • Patent number: 5863864
    Abstract: Saccharincarboxylic acids and -carboxylic acid esters of the formula I ##STR1## where the substituents have the following meanings: L and M are hydrogen, alkyl, alkoxy, alkylthio, chlorine, cyano, alkylsulfonyl, nitro or trifluoromethyl;Z is hydrogen, alkyl, cycloalkyl, alkyl, aryl or aralkyl;R is H or C.sub.1 -C.sub.6 -alkyl,are prepared by reacting corresponding bromo- or iodo-substituted saccharin derivatives of the formula II ##STR2## where L, M and Z have the abovementioned meanings, or if Z.noteq.H, compounds of the formula III ##STR3## in the presence of a palladium, nickel, cobalt or rhodium transition metal catalyst and of a base with carbon monoxide and water or a C.sub.1 -C.sub.6 -alcohol under elevated pressure.
    Type: Grant
    Filed: February 3, 1997
    Date of Patent: January 26, 1999
    Assignee: BASF Aktiengesellschaft
    Inventors: Peter Plath, Harald Rang, Karl-Otto Westphalen, Matthias Gerber, Helmut Walter
  • Patent number: 5856504
    Abstract: A method for producing a 1,2-benzisothiazole characterized by treating a 2-(alkylthio)benzaldehyde oxime with a halogen compound; a method for producing a 3-halo-1,2-benzisothiazole characterized by treating a 1,2-benzisothiazole with a halogenating agent; and a method for producing a 1-(1,2-benzisothiazol-3-yl)piperazine characterized by reacting the obtained 3-halo-1,2-benzisothiazoles with a piperazine. By the method of the present invention, 1,2-benzisothiazoles and 3-halo-1,2-benzisothiazoles, which are useful as intermediates for pharmaceutical compositions such as psychotropic agents, and 1-(1,2-benzisothiazole-3-yl)piperazines synthesized therefrom can be obtained in a high yield without using expensive starting materials by shorter and simpler process than conventional methods.
    Type: Grant
    Filed: May 19, 1997
    Date of Patent: January 5, 1999
    Assignee: Sumitomo Seika Chemicals Co., Ltd.
    Inventors: Hirokazu Kagano, Hiroshi Goda, Mikio Yamamoto, Shigeki Sakaue, Miki Toudou
  • Patent number: 5856349
    Abstract: 4-R.sup.4 -R.sup.5 -2-Saccharinylmethyl heterocyclic carboxylates, useful in the treatment of degenerative diseases, are prepared by reacting a 4-R.sup.4 -R.sup.5 -2-halomethylsaccharin with either a heterocyclic carboxylic acid in the presence of an acid-acceptor or the alkali metal salt of a heterocyclic carboxylic acid.
    Type: Grant
    Filed: June 6, 1997
    Date of Patent: January 5, 1999
    Assignee: Sanofi
    Inventors: Richard Paul Dunlap, Dennis John Hlasta, Ranjit Chimanlal Desai, Lee Hamilton Latimer, Chakrapani Subramanyam, John Joseph Court, Malcolm Rice Bell, Virendra Kumar
  • Patent number: 5856501
    Abstract: N-?4-(cyanoethylthiomethyl)-2-thiazolyl!guanidine--a key intermediate for preparing the pharmaceutical, famotidine--is produced by mixing in a liquid medium formed from a chemically indifferent organic solvent and water, and under an inert atmosphere, (i) a 2-guanidino-4-halomethylthiazole or a hydrohalide complex thereof, (ii) an S-(2-cyanoethyl)isothiourea or a hydrohalide complex thereof, and (iii) a strong alkali metal base. In lieu of (ii), an alkali metal salt of 2-cyanoethyl-1-thiol can be used, and in such case use of (iii) is optional, but preferable.
    Type: Grant
    Filed: December 11, 1997
    Date of Patent: January 5, 1999
    Assignee: Albemarle Corporation
    Inventors: Arcelio J. Malcolm, Tse-Chong Wu
  • Patent number: 5856502
    Abstract: This invention relates to reactive derivatives of 2-(2-aminothiazol-4-yl)-2-methoxyimino acetic acid and 1H-tetrazol-1-acetic acid of the following general formula I, ##STR1## wherein ##STR2## as well as to use thereof in the manufacture of cephalosporin antibiotics such as cefotaxime, ceftriaxone and cefazolin.
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: January 5, 1999
    Assignee: Lupin Laboratories Limited
    Inventors: Debashish Datta, Vinod George, Bishwa Prakash Rai
  • Patent number: 5856507
    Abstract: Methods for the preparation of biphenyl isoxazole sulfonamides and intermediates thereof. The present invention also relates to the novel intermediates prepared by these methods. The biphenyl isoxazole sulfonamides prepared by the present methods are endothelin antagonists useful, inter alia, for the treatment of hypertension.
    Type: Grant
    Filed: January 21, 1997
    Date of Patent: January 5, 1999
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Richard P. Polniaszek, Xuebao Wang, Jeffrey S. DePue, Chennagiri R. Pandit, Kumar G. Gadamasetti, Yadagiri Pendri, Eduardo J. Martinez
  • Patent number: 5852191
    Abstract: Boron complexes of certain bis-heterocyclic compounds are provided. The complexes resemble monomethine cyanines and are useful for imparting fluorescent properties to materials by covalent and noncovalent association. The compounds have the following general formula: ##STR1## wherein the dotted lines Z.sub.1 and Z.sub.2 represent the atoms necessary to complete a structure selected from the group consisting of one ring, two fused rings, and three fused rings, each said ring having five or six atoms, and each said ring comprising carbon atoms and, optionally, no more than two atoms selected from oxygen, nitrogen and sulfur, and R.sub.1 through R.sub.5 represent various atoms or groups and M is Cl or F.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 22, 1998
    Assignee: Carnegie Mellon University
    Inventors: Bhalchandra M. Karandikar, Alan S. Waggoner, Ratnakar B. Mujumdar
  • Patent number: 5847150
    Abstract: A solid phase method for the synthesis of a plurality of differently substituted 2-methylenethiazoles with a wide variety of side-chain substituents as compounds of potential therapeutic interest. The 2-methylenethiazoles are prepared by acylation of a substrate-bound primary or secondary amine with cyanoacetic acid and reaction of the resulting cyanoacetamide with an isothiocyanate in the presence of a base. Alkylation with an appropriate alkyl halide under acidic conditions yields differently substituted, support-bound 2-methylene-2,3-dihydrothiazoles. These may be screened on the substrate or cleaved from the substrate and then screened in solution. The efficient synthesis of a wide variety of 2-methylenethiazoles using automated synthesis technology of the present method makes these compounds attractive candidates for the generation and rapid screening of diverse thiazole-based libraries.
    Type: Grant
    Filed: April 16, 1997
    Date of Patent: December 8, 1998
    Assignee: Novo Nordisk A/S
    Inventor: Florencio Zaragoza Dorwald
  • Patent number: 5846988
    Abstract: Compounds useful as cytoprotective agents are disclosed. The compounds possess dual activity, containing a phenolic portion selected to have antioxidant or free radical scavenging properties and a thiazolidine-4-carboxylate portion selected for its potential to act as a cysteine prodrug.
    Type: Grant
    Filed: October 20, 1997
    Date of Patent: December 8, 1998
    Assignee: Alcon Laboratories, Inc.
    Inventor: Mark R. Hellberg
  • Patent number: 5847156
    Abstract: 1,4-Diketopyrrolopyrroles of the formula ##STR1## in which A and B independently of one another are a group of the formula ##STR2## R.sub.1 is a long-chain radical containing a reactive group capable of polymerization, and R.sub.2 is C.sub.1 -C.sub.6 alkyl, ##STR3## or R.sub.1. The novel diketopyrrolopyrroles are suitable for preparing coloured polymers with unexpectedly advantageous colour effects.
    Type: Grant
    Filed: January 29, 1997
    Date of Patent: December 8, 1998
    Assignee: Ciba Specialty Chemicals Corporation
    Inventors: Sameer Hosam Eldin, Abul Iqbal
  • Patent number: 5843975
    Abstract: The present invention relates to isoindole derivatives, and more particularly to 5-(hydroxymethyl)oxazolidine-2-one derivatives which are substituted at the 3 position by an indazole, benzisoxazole or benzisothiazole ring system, to a process for their preparation and to their application in therapy.
    Type: Grant
    Filed: December 2, 1997
    Date of Patent: December 1, 1998
    Assignee: Synthelabo
    Inventors: Samir Jegham, Frederic Puech, Philippe Burnier
  • Patent number: 5840738
    Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.
    Type: Grant
    Filed: June 25, 1997
    Date of Patent: November 24, 1998
    Assignee: Eli Lilly and Company
    Inventors: Michael Gregory Bell, Thomas Alan Crowell, Christine Ann Droste, Cynthia Darshini Jesudason, Donald Paul Matthews, John Hampton McDonald, III, David Andrew Neel, Christopher John Rito, Anthony John Shuker, Mark Alan Winter
  • Patent number: 5834500
    Abstract: Sulfur-containing heterocyclic bradykinin antagonists, process for their preparation, and their useCompounds of the formula (I) ##STR1## in which one of the radicals X.sub.1, X.sub.2 or X.sub.3 is C--O--R.sup.2 and the other X.sub.1, X.sub.2, and X.sub.3, in each case, and X.sub.4, are then, identically or differently, N or CR.sup.1 ; R.sup.1 and R.sup.3 are, identically or differently, H, halogen, (C.sub.1 -C.sub.6)-alkyl, O--R.sup.6, S--R.sup.6, NHR.sup.6, (C.sub.6 -C.sub.12)-aryl, (C.sub.6 -C.sub.12)-aryl-(C.sub.1 -C.sub.3)-alkyl, C(O)--OR.sup.6, C(O)--H, (C.sub.2 -C.sub.5)-alkenyl, NO.sub.2, SO.sub.3 R.sup.7, CN or C(O)--NHR.sup.8, where alkyl, aryl and alkenyl can optionally be substituted.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: November 10, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Adalbert Wagner, Holger Heitsch, Gerhard Nolken, Klaus Wirth, Bernward Scholkens